Tocagen (TOCA) Posts Wider Q4 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Tocagen Inc. (TOCA) PT Lowered to $25 at Chardan Capital Markets
February 28, 2019 8:52 AM ESTChardan Capital Markets analyst Gbola Amusa lowered the price target on Tocagen Inc. (NASDAQ: TOCA) to $25.00 (from $30.00) while maintaining a Buy rating.
Amusa commented, "Yesterday, after market close, Tocagen reported 4Q18 & FY18 results, and provided updates on its development path for cancer-selective gene... More
